Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes

Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes

15 Nov 2022
Dolutegravir: A better choice for HIV viral suppression in pregnancy?

Dolutegravir: A better choice for HIV viral suppression in pregnancy?

13 Nov 2022 bởiRoshini Claire Anthony

Among pregnant individuals on antiretroviral therapy (ART) for HIV-1 infection, those on dolutegravir had the greatest viral suppression rates at delivery, a recent US-based observational study showed. However, birth outcomes generally did not differ between dolutegravir recipients and those on various other ART regimens.

Dolutegravir: A better choice for HIV viral suppression in pregnancy?

13 Nov 2022
Menopause occurs early among women with diabetes

Menopause occurs early among women with diabetes

09 Nov 2022
Ovarian reserve damage less with ablation vs cystectomy for endometrioma

Ovarian reserve damage less with ablation vs cystectomy for endometrioma

07 Nov 2022

In the treatment of patients with endometrioma, both ablation and cystectomy cause significant damage to ovarian reserve, although the extent of damage appears to be less with ablation, as shown in a study.

Ovarian reserve damage less with ablation vs cystectomy for endometrioma

07 Nov 2022
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV

Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV

07 Nov 2022 bởiJairia Dela Cruz

For pregnant women with HIV who are receiving dolutegravir (DTG)-based therapies, the two-drug regimen works just as well as three-drug regimens at keeping the viral load to "undetectable" levels without exerting serious adverse effects on neonatal outcomes, according to a study presented at HIV Glasgow 2022 Congress.

Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV

07 Nov 2022